申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP2447264A1
公开(公告)日:2012-05-02
The present invention provides a compound of formula (I):
wherein R1a is optionally substituted C1-6 alkyl, etc.; R1m is hydrogen atom, etc.; G1, G2, G3 and G4 are (i), etc. ((i) G1 is -N(R1b)-, G2 is -CO-, G3 is -C(R1c)(R1d)-, and G4 is oxygen, etc.); R1b is optionally substituted C1-6 alkyl, etc.; R1c and R1d are each independently optionally substituted C1-6 alkyl, etc.; R2 is optionally substituted C1-6 alkyl, etc.; R3a, R3b, R3c, and R3d are each independently a group: -A-B (A is a single bond, etc., B is hydrogen atom, etc.), etc.; n is 1, etc.; R5 is C1-4 alkoxycarbonyl, etc., or a pharmaceutically acceptable salt thereof, which is useful as a renin inhibitor.
本发明提供了一种式 (I) 的化合物:
其中R1a是任选取代的C1-6烷基等;R1m是氢原子等;G1、G2、G3和G4是(i)等((i)G1是-N(R1b)-,G2是-CO-,G3是-C(R1c)(R1d)-,G4是氧等);R1b是任选取代的C1-6烷基等;R1c和R1d各自独立地是任选取代的C1-6烷基等;R2是任选取代的C1-6烷基等。R1c和R1d各自独立地为任选取代的C1-6烷基等;R2为任选取代的C1-6烷基等;R3a、R3b、R3c和R3d各自独立地为以下基团:-A-B(A为单键等、B是氢原子等)等;n是1等;R5是C1-4烷氧基羰基等,或其药学上可接受的盐,可用作肾素抑制剂。